Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.2bn reported value -3.2% vs Q3 2021
90positions
49.3%in top 10
19 new 31 added 32 reduced 17 sold out vs Q3 2021

Options: 12 call positions ($187.8m notional), 5 put positions ($171.1m notional) – listed below, not included above.

Holdings, Q4 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 833,750 $89.8m7.45% 7.45% AddedShares held: Q1 2021 695.5k, Q2 2021 666.7k, Q3 2021 634.7k, Q4 2021 833.8k +199.1k +199,080 31.4%
2 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 6,389,538 $85.0m7.05% 7.05% AddedShares held: Q1 2021 2.4m, Q2 2021 3.8m, Q3 2021 6.0m, Q4 2021 6.4m +401.4k +401,375 6.7%
3 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 391,920 $84.7m7.02% 7.02% ReducedShares held: Q1 2021 486.5k, Q2 2021 442.9k, Q3 2021 444.5k, Q4 2021 391.9k -52.6k -52,551 -11.8%
4 DANAHER CORPORATION COM DHR DHR 170,053 $56.0m4.64% 4.64% AddedShares held: Q1 2021 177.5k, Q2 2021 204.7k, Q3 2021 147.9k, Q4 2021 170.1k +22.1k +22,115 14.9%
5 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 949,224 $55.3m4.58% 4.58% AddedShares held: Q1 2021 992.3k, Q2 2021 985.7k, Q3 2021 890.8k, Q4 2021 949.2k +58.4k +58,416 6.6%
6 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 403,678 $54.3m4.50% 4.50% ReducedShares held: Q1 2021 311.9k, Q2 2021 241.8k, Q3 2021 445.2k, Q4 2021 403.7k -41.5k -41,525 -9.3%
7 AVANTOR INC COM AVTR AVTR 1,125,465 $47.4m3.93% 3.93% ReducedShares held: Q1 2021 959.0k, Q2 2021 974.6k, Q3 2021 1.3m, Q4 2021 1.1m -166.5k -166,549 -12.9%
8 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 315,129 $43.4m3.60% 3.60% NewShares held: Q1 2021 242.2k, Q2 2021 0, Q3 2021 0, Q4 2021 315.1k
9 ARK ETF TR GENOMIC REV ETF ARKG ARKG 664,484 $40.7m3.37% 3.37% ReducedShares held: Q1 2021 806.9k, Q2 2021 773.5k, Q3 2021 689.5k, Q4 2021 664.5k -25.0k -25,017 -3.6%
10 ENVISTA HOLDINGS CORPORATION COM NVST NVST 849,298 $38.3m3.17% 3.17% AddedShares held: Q1 2021 732.7k, Q2 2021 656.1k, Q3 2021 810.9k, Q4 2021 849.3k +38.4k +38,417 4.7%
11 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 10,573,302 $35.6m2.95% 2.95% ReducedShares held: Q1 2021 16.9m, Q2 2021 16.7m, Q3 2021 11.6m, Q4 2021 10.6m -1.0m -1,031,688 -8.9%
12 MCKESSON CORP COM MCK MCK 136,111 $33.9m2.81% 2.81% ReducedShares held: Q1 2021 123.0k, Q2 2021 75.0k, Q3 2021 161.7k, Q4 2021 136.1k -25.6k -25,597 -15.8%
13 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 6,440,572 $30.9m2.56% 2.56% ReducedShares held: Q1 2021 4.8m, Q2 2021 5.6m, Q3 2021 6.8m, Q4 2021 6.4m -409.3k -409,262 -6.0%
14 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 567,205 $25.0m2.08% 2.08% AddedShares held: Q1 2021 852.2k, Q2 2021 112.7k, Q3 2021 401.7k, Q4 2021 567.2k +165.6k +165,551 41.2%
15 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 592,478 $22.9m1.90% 1.90% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 592.5k
16 ORTHO CLINICAL DIAGNOSTICS H ORD SHS OCDX OCDX 886,140 $19.0m1.57% 1.57% ReducedShares held: Q1 2021 1.4m, Q2 2021 1.4m, Q3 2021 915.0k, Q4 2021 886.1k -28.8k -28,846 -3.1%
17 R1 RCM INC COM RCM RCM 733,132 $18.7m1.55% 1.55% ReducedShares held: Q1 2021 0, Q2 2021 770.0k, Q3 2021 764.8k, Q4 2021 733.1k -31.6k -31,648 -4.1%
18 CENTENE CORP DEL COM CNC CNC 224,613 $18.5m1.53% 1.53% AddedShares held: Q1 2021 91.1k, Q2 2021 68.0k, Q3 2021 141.1k, Q4 2021 224.6k +83.5k +83,506 59.2%
19 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 2,301,498 $18.4m1.53% 1.53% ReducedShares held: Q1 2021 4.4m, Q2 2021 3.8m, Q3 2021 3.6m, Q4 2021 2.3m -1.3m -1,253,306 -35.3%
20 ICON PLC SHS ICLR ICLR 51,867 $16.1m1.33% 1.33% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 71.9k, Q4 2021 51.9k -20.0k -20,044 -27.9%
21 ELEVANCE HEALTH INC COM ELV ELV 34,294 $15.9m1.32% 1.32% AddedShares held: Q1 2021 63.9k, Q2 2021 10.1k, Q3 2021 31.6k, Q4 2021 34.3k +2.7k +2,666 8.4%
22 FATE THERAPEUTICS INC COM FATE FATE 254,790 $14.9m1.24% 1.24% ReducedShares held: Q1 2021 321.8k, Q2 2021 346.3k, Q3 2021 260.9k, Q4 2021 254.8k -6.1k -6,105 -2.3%
23 HEALTHEQUITY INC COM HQY HQY 333,352 $14.7m1.22% 1.22% AddedShares held: Q1 2021 0, Q2 2021 197.5k, Q3 2021 114.4k, Q4 2021 333.4k +219.0k +218,974 191.4%
24 LABORATORY CORP AMER HLDGS COM NEW COM NEW 45,522 $14.3m1.19% 1.19% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 128.3k, Q4 2021 45.5k -82.8k -82,789 -64.5%
25 HUMANA INC COM HUM HUM 27,382 $12.7m1.05% 1.05% AddedShares held: Q1 2021 24.8k, Q2 2021 18.7k, Q3 2021 24.1k, Q4 2021 27.4k +3.3k +3,299 13.7%
26 HCA HEALTHCARE INC COM HCA HCA 49,094 $12.6m1.05% 1.05% AddedShares held: Q1 2021 85.4k, Q2 2021 8.3k, Q3 2021 38.4k, Q4 2021 49.1k +10.7k +10,728 28.0%
27 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 231,787 $12.1m1.01% 1.01% AddedShares held: Q1 2021 300.6k, Q2 2021 117.5k, Q3 2021 230.7k, Q4 2021 231.8k +1.0k +1,043 0.5%
28 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 70,240 $11.9m0.99% 0.99% AddedShares held: Q1 2021 80.9k, Q2 2021 51.1k, Q3 2021 59.2k, Q4 2021 70.2k +11.0k +11,007 18.6%
29 IONIS PHARMACEUTICALS INC COM IONS IONS 384,789 $11.7m0.97% 0.97% ReducedShares held: Q1 2021 0, Q2 2021 442.0k, Q3 2021 450.5k, Q4 2021 384.8k -65.7k -65,712 -14.6%
30 ARK ETF TR INNOVATION ETF ARKK ARKK 119,118 $11.3m0.93% 0.93% AddedShares held: Q1 2021 82.0k, Q2 2021 85.0k, Q3 2021 35.0k, Q4 2021 119.1k +84.1k +84,118 240.3%
31 NANOSTRING TECHNOLOGIES INC COM NSTG NSTG 265,695 $11.2m0.93% 0.93% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 168.7k, Q4 2021 265.7k +97.0k +97,027 57.5%
32 GUARDANT HEALTH INC COM GH GH 100,334 $10.0m0.83% 0.83% ReducedShares held: Q1 2021 40.2k, Q2 2021 1.8k, Q3 2021 100.4k, Q4 2021 100.3k -27 -27 -0.0%
33 MAGELLAN HEALTH INC COM NEW MGLN MGLN 104,700 $9.9m0.82% 0.82% UnchangedShares held: Q1 2021 104.7k, Q2 2021 104.7k, Q3 2021 104.7k, Q4 2021 104.7k
34 EXELIXIS INC COM EXEL EXEL 535,700 $9.8m0.81% 0.81% AddedShares held: Q1 2021 0, Q2 2021 180.0k, Q3 2021 516.3k, Q4 2021 535.7k +19.4k +19,393 3.8%
35 NATERA INC COM NTRA NTRA 102,071 $9.5m0.79% 0.79% ReducedShares held: Q1 2021 57.7k, Q2 2021 9.3k, Q3 2021 112.2k, Q4 2021 102.1k -10.1k -10,118 -9.0%
36 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 181,151 $9.1m0.75% 0.75% AddedShares held: Q1 2021 164.4k, Q2 2021 174.2k, Q3 2021 179.4k, Q4 2021 181.2k +1.8k +1,785 1.0%
37 QIAGEN NV SHS NEW SHS NEW 162,534 $9.0m0.75% 0.75% AddedShares held: Q1 2021 454.7k, Q2 2021 651.0k, Q3 2021 143.1k, Q4 2021 162.5k +19.4k +19,425 13.6%
38 ZOGENIX INC COM NEW ZGNX ZGNX 550,966 $9.0m0.74% 0.74% ReducedShares held: Q1 2021 823.2k, Q2 2021 495.9k, Q3 2021 774.6k, Q4 2021 551.0k -223.6k -223,625 -28.9%
39 SYNEOS HEALTH INC CL A INCR INCR 85,612 $8.8m0.73% 0.73% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 85.6k
40 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 73,169 $8.6m0.71% 0.71% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 113.9k, Q4 2021 73.2k -40.7k -40,685 -35.7%
41 INSULET CORP COM PODD PODD 30,172 $8.0m0.67% 0.67% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 30.2k
42 BIOGEN INC COM BIIB BIIB 33,041 $7.9m0.66% 0.66% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 33.0k
43 ARGENX SE SPONSORED ADR ARGX ARGX 21,496 $7.5m0.62% 0.62% AddedShares held: Q1 2021 35.9k, Q2 2021 0, Q3 2021 5.7k, Q4 2021 21.5k +15.8k +15,750 274.1%
44 CERNER CORP COM CERN CERN 77,543 $7.2m0.60% 0.60% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 77.5k
45 LIQUIDIA CORPORATION COM NEW LQDA LQDA 1,447,898 $7.1m0.58% 0.58% AddedShares held: Q1 2021 500.0k, Q2 2021 979.0k, Q3 2021 929.0k, Q4 2021 1.4m +518.8k +518,849 55.9%
46 IQVIA HLDGS INC COM IQV IQV 24,618 $6.9m0.58% 0.58% AddedShares held: Q1 2021 5.9k, Q2 2021 5.7k, Q3 2021 6.8k, Q4 2021 24.6k +17.8k +17,828 262.6%
47 XENON PHARMACEUTICALS INC COM XENE XENE 209,519 $6.5m0.54% 0.54% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 209.5k
48 ANAPTYSBIO INC COM ANAB ANAB 182,612 $6.3m0.53% 0.53% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 78.1k, Q4 2021 182.6k +104.6k +104,558 134.0%
49 PERKINELMER INC COM RVTY RVTY 30,869 $6.2m0.51% 0.51% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 47.1k, Q4 2021 30.9k -16.2k -16,212 -34.4%
50 SI-BONE INC COM SIBN SIBN 258,094 $5.7m0.48% 0.48% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 150.0k, Q4 2021 258.1k +108.1k +108,094 72.1%
51 NEVRO CORP COM NVRO NVRO 66,074 $5.4m0.44% 0.44% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 66.1k
52 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 63,163 $5.3m0.44% 0.44% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 63.2k
53 MERCK & CO INC COM MRK MRK 19,456 $5.0m0.42% 0.42% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 19.5k
54 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 201,384 $4.6m0.38% 0.38% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 201.4k
55 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 194,589 $3.8m0.32% 0.32% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 160.0k, Q4 2021 194.6k +34.6k +34,589 21.6%
56 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 87,795 $3.7m0.30% 0.30% ReducedShares held: Q1 2021 0, Q2 2021 75.0k, Q3 2021 327.8k, Q4 2021 87.8k -240.0k -240,015 -73.2%
57 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 9,825 $3.5m0.29% 0.29% AddedShares held: Q1 2021 7.7k, Q2 2021 7.7k, Q3 2021 9.4k, Q4 2021 9.8k +390 +390 4.1%
58 DEXCOM INC COM DXCM DXCM 6,401 $3.4m0.28% 0.28% UnchangedShares held: Q1 2021 18.7k, Q2 2021 9.5k, Q3 2021 6.4k, Q4 2021 6.4k
59 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,117,898 $3.4m0.28% 0.28% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 397.9k, Q4 2021 1.1m +720.0k +719,958 180.9%
60 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 797,694 $3.1m0.26% 0.26% ReducedShares held: Q1 2021 410.6k, Q2 2021 229.3k, Q3 2021 872.7k, Q4 2021 797.7k -75.0k -75,000 -8.6%
61 AGILENT TECHNOLOGIES INC COM A A 19,431 $3.1m0.26% 0.26% AddedShares held: Q1 2021 15.3k, Q2 2021 15.3k, Q3 2021 18.7k, Q4 2021 19.4k +771 +771 4.1%
62 CUREVAC N V COM CVAC CVAC 85,017 $2.9m0.24% 0.24% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 85.0k
63 GRITSTONE BIO INC COM GRTS GRTS 170,125 $2.2m0.18% 0.18% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 170.1k
64 MIRATI THERAPEUTICS INC COM MRTX MRTX 14,840 $2.2m0.18% 0.18% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 9.4k, Q4 2021 14.8k +5.5k +5,485 58.6%
65 KARUNA THERAPEUTICS INC COM COM 15,934 $2.1m0.17% 0.17% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 25.0k, Q4 2021 15.9k -9.1k -9,066 -36.3%
66 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 401,540 $2.1m0.17% 0.17% AddedShares held: Q1 2021 0, Q2 2021 473.1k, Q3 2021 398.1k, Q4 2021 401.5k +3.5k +3,466 0.9%
67 SANOFI SPONSORED ADR SNY SNY 38,672 $1.9m0.16% 0.16% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 259.1k, Q4 2021 38.7k -220.5k -220,456 -85.1%
68 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 25,137 $1.7m0.14% 0.14% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 25.1k
69 SURGALIGN HOLDINGS INC COM RTIX RTIX 1,918,743 $1.4m0.11% 0.11% ReducedShares held: Q1 2021 2.6m, Q2 2021 3.9m, Q3 2021 3.5m, Q4 2021 1.9m -1.6m -1,589,793 -45.3%
70 ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAPY ADAPY 348,716 $1.3m0.11% 0.11% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 444.9k, Q4 2021 348.7k -96.2k -96,171 -21.6%
71 REPLIGEN CORP COM RGEN RGEN 4,584 $1.2m0.10% 0.10% AddedShares held: Q1 2021 1.4k, Q2 2021 3.7k, Q3 2021 4.4k, Q4 2021 4.6k +182 +182 4.1%
72 AVROBIO INC COM COM 304,989 $1.2m0.10% 0.10% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 359.5k, Q4 2021 305.0k -54.5k -54,491 -15.2%
73 MYOMO INC COM NEW MYO MYO 150,000 $1.0m0.09% 0.09% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 150.0k, Q4 2021 150.0k
74 VOCERA COMMUNICATIONS INC COM VCRA VCRA 14,970 $970.7k0.08% 0.08% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 15.0k
75 MILESTONE PHARMACEUTICALS IN COM MIST MIST 147,165 $963.9k0.08% 0.08% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 113.6k, Q4 2021 147.2k +33.6k +33,568 29.6%
76 ENSIGN GROUP INC COM ENSG ENSG 10,397 $873.5k0.07% 0.07% UnchangedShares held: Q1 2021 28.9k, Q2 2021 9.0k, Q3 2021 10.4k, Q4 2021 10.4k
77 HESKA CORP COM RESTRC NEW HSKA HSKA 4,525 $825.8k0.07% 0.07% UnchangedShares held: Q1 2021 11.0k, Q2 2021 3.4k, Q3 2021 4.5k, Q4 2021 4.5k
78 AC IMMUNE SA SHS ACIU ACIU 153,380 $759.2k0.06% 0.06% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 221.7k, Q4 2021 153.4k -68.4k -68,369 -30.8%
79 ASSEMBLY BIOSCIENCES INC COM COM 310,000 $722.3k0.06% 0.06% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 350.0k, Q4 2021 310.0k -40.0k -40,000 -11.4%
80 LOGICBIO THERAPEUTICS INC COM LOGC LOGC 291,101 $672.4k0.06% 0.06% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 349.9k, Q4 2021 291.1k -58.8k -58,818 -16.8%
81 CYCLERION THERAPEUTICS INC COM COM 371,955 $639.8k0.05% 0.05% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 372.0k, Q4 2021 372.0k
82 MERUS N V COM MRUS MRUS 19,000 $604.2k0.05% 0.05% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 19.0k
83 ORCHARD THERAPEUTICS PLC ADS ORTX ORTX 419,581 $553.8k0.05% 0.05% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 569.6k, Q4 2021 419.6k -150.0k -150,000 -26.3%
84 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 114,008 $502.8k0.04% 0.04% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 114.0k, Q4 2021 114.0k
85 GOSSAMER BIO INC COM GOSS GOSS 39,910 $451.4k0.04% 0.04% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 149.9k, Q4 2021 39.9k -110.0k -110,000 -73.4%
86 SONIDA SENIOR LIVING INC COM SNDA SNDA 15,209 $433.3k0.04% 0.04% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 15.2k
87 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 259,470 $415.2k0.03% 0.03% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 899.6k, Q4 2021 259.5k -640.1k -640,099 -71.2%
88 BROOKDALE SR LIVING INC COM BKD BKD 79,146 $408.4k0.03% 0.03% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 79.1k
89 F-STAR THERAPEUTICS INC COM COM 49,933 $250.7k0.02% 0.02% UnchangedShares held: Q1 2021 0, Q2 2021 100.0k, Q3 2021 49.9k, Q4 2021 49.9k
90 GLYCOMIMETICS INC COM COM 100,000 $144.0k0.01% 0.01% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 100.0k

Sold out since Q3 2021

SecurityTickerShares held beforeValue then
ACCELERON PHARMA INC XLRN XLRN 349,494 $60.1m349.5k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 464,801 $27.8m464.8k shares
CATALENT INC CTLT CTLT 184,299 $24.5m184.3k shares
MASIMO CORP MASI MASI 67,000 $18.1m67.0k shares
GOHEALTH INC 1,261,723 $6.3m1.3m shares
HILL ROM HLDGS INC HRC HRC 30,000 $4.5m30.0k shares
EVOLENT HEALTH INC EVH EVH 100,170 $3.1m100.2k shares
MORPHIC HLDG INC MORF MORF 43,600 $2.5m43.6k shares
OUTSET MED INC OM OM 47,500 $2.3m47.5k shares
HEALTHSTREAM INC HSTM HSTM 77,812 $2.2m77.8k shares
MAGENTA THERAPEUTICS INC 198,879 $1.4m198.9k shares
AKOYA BIOSCIENCES INC AKYA AKYA 91,568 $1.3m91.6k shares
AMN HEALTHCARE SVCS INC AMN AMN 10,000 $1.1m10.0k shares
PHASEBIO PHARMACEUTICALS INC PHAS PHAS 300,000 $933.0k300.0k shares
TELIGENT INC NEW 1,069,465 $426.7k1.1m shares
CROSS CTRY HEALTHCARE INC CCRN CCRN 20,000 $424.8k20.0k shares
FREQUENCY THERAPEUTICS INC 30,000 $211.8k30.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 286,600 $114.0m286.6k shares New
GLAXOSMITHKLINE PLC Call Call 1,503,700 $66.3m1.5m shares Unchanged
ASTRAZENECA PLC Call Call 572,300 $33.3m572.3k shares Added
ISHARES TR IWM · Put IWMPut 125,000 $27.8m125.0k shares New
ISHARES TR IWO · Put IWOPut 90,000 $26.4m90.0k shares New
VERTEX PHARMACEUTICALS INC VRTX · Call VRTXCall 94,100 $20.7m94.1k shares Reduced
COMMUNITY HEALTH SYS INC NEW CYH · Call CYHCall 1,277,200 $17.0m1.3m shares Added
ARK ETF TR ARKG · Call ARKGCall 243,800 $14.9m243.8k shares New
SPDR SER TR XBI · Call XBICall 113,800 $12.7m113.8k shares New
TEVA PHARMACEUTICAL INDS LTD Call Call 962,400 $7.7m962.4k shares Unchanged
HORIZON THERAPEUTICS PUB L HZNP · Call HZNPCall 70,000 $7.5m70.0k shares Unchanged
MERCK & CO INC MRK · Call MRKCall 48,700 $3.7m48.7k shares Unchanged
PROGYNY INC PGNY · Put PGNYPut 50,000 $2.5m50.0k shares New
ACADIA PHARMACEUTICALS INC ACAD · Call ACADCall 84,600 $2.0m84.6k shares Unchanged
UNITED THERAPEUTICS CORP DEL UTHR · Call UTHRCall 7,600 $1.6m7.6k shares New
JOINT CORP JYNT · Put JYNTPut 5,500 $361.3k5.5k shares New
MANNKIND CORP MNKD · Call MNKDCall 50,000 $218.5k50.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17